Es gab 50 kürzliche Insider-Transaktionen für Vaxart, Inc. (VXRT), darunter 26 Käufe und 23 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $3.3M und die gesamten Insider-Verkäufe auf $273.95K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Lee Phillip E, Tucker Sean, Cummings James F.. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — VXRT
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2033-03-17 |
Lee Phillip E |
Chief Financial Officer |
RSU-Zuteilung |
410,000 |
$0.78 |
$319.8K |
410,000 |
| 2026-03-28 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Steuereinbehalt |
3,924 |
$0.65 |
$2.55K |
882,811 |
| 2026-03-28 |
Cummings James F. |
Chief Medical Officer |
RSU-Steuereinbehalt |
3,292 |
$0.65 |
$2.14K |
924,177 |
| 2026-03-24 |
Lo Steven |
President, Chief Exec Officer |
RSU-Steuereinbehalt |
126,028 |
$0.69 |
$87.46K |
2,485,606 |
| 2026-03-24 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Steuereinbehalt |
36,418 |
$0.69 |
$25.27K |
886,735 |
| 2026-03-24 |
Cummings James F. |
Chief Medical Officer |
RSU-Steuereinbehalt |
30,551 |
$0.69 |
$21.2K |
927,469 |
| 2026-03-24 |
Berg Edward B |
SVP, General Counsel |
RSU-Steuereinbehalt |
36,418 |
$0.69 |
$25.27K |
755,368 |
| 2026-03-18 |
Lo Steven |
President, Chief Exec Officer |
RSU-Steuereinbehalt |
22,425 |
$0.63 |
$14.23K |
2,611,634 |
| 2026-03-18 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Steuereinbehalt |
8,072 |
$0.63 |
$5.12K |
923,153 |
| 2026-03-18 |
Cummings James F. |
Chief Medical Officer |
RSU-Steuereinbehalt |
6,772 |
$0.63 |
$4.3K |
958,020 |
| 2026-03-18 |
Berg Edward B |
SVP, General Counsel |
RSU-Steuereinbehalt |
8,072 |
$0.63 |
$5.12K |
791,786 |
| 2026-03-16 |
Lo Steven |
President, Chief Exec Officer |
RSU-Zuteilung |
1,543,000 |
$0.68 |
$1.05M |
1,543,000 |
| 2026-03-16 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Zuteilung |
410,000 |
$0.68 |
$278.6K |
410,000 |
| 2026-03-16 |
Cummings James F. |
Chief Medical Officer |
RSU-Zuteilung |
455,000 |
$0.68 |
$309.17K |
455,000 |
| 2026-03-16 |
Berg Edward B |
SVP, General Counsel |
RSU-Zuteilung |
225,000 |
$0.68 |
$152.89K |
225,000 |
| 2026-03-16 |
Grasman Jeroen Nicolaas |
Chief Financial Officer |
RSU-Zuteilung |
455,000 |
$0.68 |
$309.17K |
455,000 |
| 2026-02-02 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Steuereinbehalt |
9,265 |
$0.61 |
$5.64K |
731,225 |
| 2026-02-02 |
Cummings James F. |
Chief Medical Officer |
RSU-Steuereinbehalt |
7,965 |
$0.61 |
$4.85K |
737,792 |
| 2026-02-02 |
Berg Edward B |
SVP, General Counsel |
RSU-Steuereinbehalt |
9,265 |
$0.61 |
$5.64K |
684,858 |
| 2025-12-04 |
Lo Steven |
President, Chief Exec Officer |
RSU-Steuereinbehalt |
54,153 |
$0.37 |
$20.04K |
1,787,559 |
| 2025-11-17 |
Heron Elaine J |
Director |
Informierter Kauf |
23,217 |
$0.39 |
$9.12K |
79,783 |
| 2025-11-17 |
Watson W. Mark |
Director |
Informierter Kauf |
15,000 |
$0.41 |
$6.15K |
119,125 |
| 2025-08-15 |
Finney Kevin |
Director |
Informierter Kauf |
50,000 |
$0.35 |
$17.5K |
154,771 |
| 2025-07-30 |
Finney Kevin |
Director |
Informierter Kauf |
25,874 |
$0.38 |
$9.83K |
104,771 |
| 2025-07-29 |
Watson W. Mark |
Director |
Informierter Kauf |
10,000 |
$0.41 |
$4.05K |
104,125 |
| 2025-07-28 |
Finney Kevin |
Director |
Informierter Kauf |
20,000 |
$0.40 |
$8K |
78,897 |
| 2025-07-25 |
Finney Kevin |
Director |
Informierter Kauf |
20,000 |
$0.39 |
$7.8K |
58,897 |
| 2025-07-17 |
Finney Kevin |
Director |
Informierter Kauf |
794 |
$0.38 |
$301.72 |
38,897 |
| 2025-06-13 |
Heron Elaine J |
Director |
RSU-Zuteilung |
16,000 |
- |
- |
56,566 |
| 2025-06-13 |
Watson W. Mark |
Director |
RSU-Zuteilung |
16,000 |
- |
- |
94,125 |
| 2025-06-13 |
Finney Michael J. |
Director |
RSU-Zuteilung |
95,400 |
$0.70 |
$66.78K |
95,400 |
| 2025-06-13 |
Wheadon David E. |
Director |
RSU-Zuteilung |
16,000 |
- |
- |
46,750 |
| 2025-06-13 |
Finney Kevin |
Director |
RSU-Zuteilung |
36,392 |
$0.70 |
$25.47K |
36,392 |
| 2025-05-19 |
Lo Steven |
President, Chief Exec Officer |
Informierter Kauf |
100,000 |
$0.49 |
$49K |
100,000 |
| 2025-05-19 |
Grasman Jeroen Nicolaas |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-05-19 |
Grasman Jeroen Nicolaas |
Chief Financial Officer |
RSU-Zuteilung |
350,000 |
- |
- |
350,000 |
| 2025-03-28 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Steuereinbehalt |
3,913 |
$0.42 |
$1.65K |
740,490 |
| 2025-03-28 |
Cummings James F. |
Chief Medical Officer |
RSU-Steuereinbehalt |
3,292 |
$0.42 |
$1.39K |
745,757 |
| 2025-03-24 |
Lo Steven |
President, Chief Exec Officer |
RSU-Zuteilung |
1,405,000 |
- |
- |
1,632,638 |
| 2025-03-24 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Zuteilung |
610,000 |
$0.51 |
$312.69K |
610,000 |
| 2025-03-24 |
Cummings James F. |
Chief Medical Officer |
RSU-Zuteilung |
50,000 |
$0.51 |
$25.63K |
50,000 |
| 2025-03-24 |
Berg Edward B |
SVP, General Counsel |
RSU-Zuteilung |
50,000 |
$0.51 |
$25.63K |
50,000 |
| 2025-03-24 |
Lee Phillip E |
Chief Financial Officer |
RSU-Zuteilung |
610,000 |
$0.51 |
$312.69K |
610,000 |
| 2025-03-18 |
Lo Steven |
President, Chief Exec Officer |
RSU-Steuereinbehalt |
22,362 |
$0.57 |
$12.75K |
227,638 |
| 2025-03-18 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Steuereinbehalt |
8,050 |
$0.57 |
$4.59K |
338,403 |
| 2025-03-18 |
Cummings James F. |
Chief Medical Officer |
RSU-Steuereinbehalt |
6,772 |
$0.57 |
$3.86K |
343,049 |
| 2025-03-18 |
Berg Edward B |
SVP, General Counsel |
RSU-Steuereinbehalt |
8,050 |
$0.57 |
$4.59K |
288,123 |
| 2025-03-18 |
Lee Phillip E |
Chief Financial Officer |
RSU-Steuereinbehalt |
8,050 |
$0.57 |
$4.59K |
225,619 |
| 2025-02-02 |
Tucker Sean |
SVP, Chief Scientific Officer |
RSU-Steuereinbehalt |
9,242 |
$0.68 |
$6.28K |
346,453 |
| 2025-02-02 |
Cummings James F. |
Chief Medical Officer |
RSU-Steuereinbehalt |
7,964 |
$0.68 |
$5.41K |
318,837 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
